These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 18322432)

  • 21. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK
    Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of foreign residents undergoing deceased donor liver transplantation in China: a single-center experience in Taiwan.
    Kuo WT; Hsia CY; Loong CC; Liu CS; Tsai HL; Tseng HS; Lee RC; Tsou MY; Wu CW; Lui WY
    Liver Transpl; 2009 Nov; 15(11):1579-85. PubMed ID: 19877223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma.
    Kneteman NM; Oberholzer J; Al Saghier M; Meeberg GA; Blitz M; Ma MM; Wong WW; Gutfreund K; Mason AL; Jewell LD; Shapiro AM; Bain VG; Bigam DL
    Liver Transpl; 2004 Oct; 10(10):1301-11. PubMed ID: 15376305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
    Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue.
    Lee HS
    Dig Dis; 2007; 25(4):296-8. PubMed ID: 17960062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded criteria for hepatocellular carcinoma and liver transplantation.
    Haberal M; Emiroglu R; Karakayali H; Moray G; Yilmaz U; Ozçay F; Bilezikci B; Arslan G
    Int Surg; 2007; 92(2):110-5. PubMed ID: 17518254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes.
    Chan SC; Fan ST; Lo CM; Liu CL; Wei WI; Chik BH; Wong J
    Ann Surg; 2008 Sep; 248(3):411-9. PubMed ID: 18791361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma.
    Takada Y; Ueda M; Ito T; Sakamoto S; Haga H; Maetani Y; Ogawa K; Kasahara M; Oike F; Egawa H; Tanaka K
    Liver Transpl; 2006 Jun; 12(6):912-9. PubMed ID: 16489583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation.
    Kishi Y; Sugawara Y; Tamura S; Kaneko J; Kokudo N; Makuuchi M
    Transpl Int; 2006 Sep; 19(9):720-5. PubMed ID: 16918532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis.
    Park YK; Kim BW; Wang HJ; Kim MW
    Transplant Proc; 2009 Jun; 41(5):1691-7. PubMed ID: 19545709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
    Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma.
    Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
    J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma.
    Karakayali H; Moray G; Sozen H; Dalgic A; Emiroglu R; Haberal M
    Transplant Proc; 2006 Mar; 38(2):575-8. PubMed ID: 16549179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.